Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Do your diabetes sensors work when oxygen is low? new study finds out

NCT ID NCT05144802

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checked how well two continuous glucose monitors (Dexcom G6 and FreeStyle Libre) work when oxygen levels are low. Thirty people with type 1 or type 2 diabetes took part. Researchers compared sensor readings to blood tests during controlled low-oxygen conditions to see if the sensors stayed accurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

May 2022

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: all population * No history of respiratory diseases (childhood asthma, respiratory allergies, exercise-induced asthma or dyspnea) * Willing to participate and able to sign an informed consent form (ICF) * Being affiliated with the French Social Security Inclusion Criteria:Patients with diabetes * type 1 diabetes mellitus or type 2 diabetes mellitus (ADA definition) * Age : 18 to 75 years * stable diabetes treatment for more than 3 months * no diabetic retinopathy * no diabetic neuropathy * no cardiovascular diseases * no contra-indication for coronary computed tomography angiography or myocardial perfusion scintigraphy. Inclusion Criteria: Healthy volunteers * Age : 18 ; 40 years * No diabetes * No persistant drug use \> 3 months except contraception * Body mass index : \[18,5 - 29,9\] kg/m2 Non-inclusion criteria : all population * Active smokers * Pregnant or breastfeeding women, women of childbearing age without effective contraception * Known allergies to the patch. * Skin lesions at the sensor site that may interfere with sensor placement or accuracy * Major cardiovascular complications within the past 3 months * Decompensated congestive heart failure * Chronic respiratory failure * Chronic renal failure * Resting ambient air O2 saturation ≤95%. * Treatment with systemic corticosteroids * Severe hypertension (≥180 mmHg systolic pressure or ≥ 100 mmHg diastolic pressure) * Any concomitant disease or condition that the investigator believes may compromise patient safety or affect the conduct of the study * Anemia (Hb\<12g/dl) * History of severe mountain sickness * Concurrent participation in another clinical research study, * Persons benefiting from enhanced protection Non-inclusion criteria: Patients with diabetes * Absolute contraindications to physical activity (HAS definitin) : * Pulmonary arterial hypertension (\> 60 mm Hg) * Presence of intra-cardiac thrombus * Acute pericardial effusion * Severe obstructive cardiomyopathy * Symptomatic aortic stenosis * Recent thrombophlebitis with or without pulmonary embolism

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 1 diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU

    Poitiers, 86000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.